Identification and characterization of circular RNAs as novel putative biomarkers to predict anti-PD-1 monotherapy response in metastatic melanoma patients – Knowledge from two independent international studies

Melanoma is the most aggressive skin malignancy with high morbidity. Anti-programmed cell death protein 1 (PD-1) monotherapy has been applied in metastatic melanoma. However, still most of the patients do not respond to anti-PD-1 and the availability of the present approved biomarkers therefore is l...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Jian-Guo, Liang, Rui, Wang, Hai-Tao, Jin, Su-Han, Hu, Wei, Frey, Benjamin, Fietkau, Rainer, Hecht, Markus, Ma, Hu, Gaipl, Udo S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2023
Materias:
Radiation and Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879779/
https://www.ncbi.nlm.nih.gov/pubmed/36696838
http://dx.doi.org/10.1016/j.neo.2023.100877

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879779/
https://www.ncbi.nlm.nih.gov/pubmed/36696838
http://dx.doi.org/10.1016/j.neo.2023.100877

Ejemplares similares